In infertile PCOS women receiving letrozole for ovulation induction, increased levels of baseline LH/FSH ratio, AMH, and free androgen index were found to be negatively associated with response to letrozole treatment [27]. The gene discussed is BRD2; the disease is polycystic ovary syndrome.